Literature DB >> 24005326

The ubiquitin ligase parkin mediates resistance to intracellular pathogens.

Paolo S Manzanillo1, Janelle S Ayres, Robert O Watson, Angela C Collins, Gianne Souza, Chris S Rae, David S Schneider, Ken Nakamura, Michael U Shiloh, Jeffery S Cox.   

Abstract

Ubiquitin-mediated targeting of intracellular bacteria to the autophagy pathway is a key innate defence mechanism against invading microbes, including the important human pathogen Mycobacterium tuberculosis. However, the ubiquitin ligases responsible for catalysing ubiquitin chains that surround intracellular bacteria are poorly understood. The parkin protein is a ubiquitin ligase with a well-established role in mitophagy, and mutations in the parkin gene (PARK2) lead to increased susceptibility to Parkinson's disease. Surprisingly, genetic polymorphisms in the PARK2 regulatory region are also associated with increased susceptibility to intracellular bacterial pathogens in humans, including Mycobacterium leprae and Salmonella enterica serovar Typhi, but the function of parkin in immunity has remained unexplored. Here we show that parkin has a role in ubiquitin-mediated autophagy of M. tuberculosis. Both parkin-deficient mice and flies are sensitive to various intracellular bacterial infections, indicating parkin has a conserved role in metazoan innate defence. Moreover, our work reveals an unexpected functional link between mitophagy and infectious disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005326      PMCID: PMC3886920          DOI: 10.1038/nature12566

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


Eukaryotic cells target invading microbes to autophagosomes via a process termed xenophagy, which plays a key role in innate immune defense. Various intracellular bacterial pathogens, including Mycobacterium tuberculosis, are targeted for xenophagy via a ubiquitin-mediated pathway that surrounds bacteria with conjugated ubiquitin chains[1-3]. Marking with polyubiquitin presumably recruits ubiquitin-binding autophagy adaptors such as p62, which in turn engage the autophagic machinery for autophagosome formation and delivery of bacteria to the lysosome[1,3,4]. While ubiquitin binding adaptors are required for xenophagy, whether ubiquitin itself directly mediates bacterial autophagy is not clear as the identities of the ubiquitinated substrate(s) and ligase(s) responsible for coating cytosol-exposed bacteria are poorly understood. In a fashion similar to xenophagy, the process of mitophagy eliminates damaged mitochondria through ubiquitin-mediated targeting to autophagosomes. A key step in mitophagy is marking of damaged mitochondria by the ubiquitin ligase PARKIN, which localizes to the organelle and directly ubiquitinates proteins on its surface[5]. Ubiquitin-tagged mitochondria are directed to the autophagosome pathway via p62[6-8] and several other factors[10], ultimately delivering the organelle to the lysosome[5]. Park2 mutations in humans are well-known risk factors for the development of Parkinson’s disease, but polymorphisms in the regulatory region of Park2, some of which result in decreased PARKIN expression[9], have been associated with increased susceptibility to the intracellular pathogens Mycobacterium leprae and Salmonella typhi[10,11]. Although a genetic link to increased infection risk has been identified, the function of PARKIN in immunity remains obscure. We have identified that PARKIN, similar to its role in mitophagy, is also important for innate defense against M. tuberculosis and other intracellular pathogens by promoting xenophagy. This work provides a possible mechanism underlying the human genetic studies linking PARKIN to increased susceptibility to bacterial infection and reveals a surprising connection between mitochondrial homeostasis and pathogen defense.

PARKIN in TB-ubiquitin colocalization

We have shown previously that upon infection of macrophages, M. tuberculosis bacilli that puncture phagosomal membranes via their ESX-1 secretion system gain access to the host cytosol but become enveloped by conjugated ubiquitin chains and are targeted to autophagosomes via p62 and NDP52[3]. Although the role of ESX-1 in autophagy induction is likely complicated[12], it is clear that approximately one-third of wild-type intracellular bacteria are targeted to autophagy during macrophage infection and that this plays a major role in host resistance to infection[2,3]. Because of the commonalities between mitophagy and autophagy of intracellular mycobacteria, and the links between Park2 polymorphisms and increased susceptibility to bacterial infection in humans, we hypothesized that PARKIN may also be recruited to M. tuberculosis-containing phagosomes and target them for ubiquitin-mediated autophagy. Indeed, after infection of murine bone marrow-derived macrophages (BMDMs) with M. tuberculosis expressing mCherry, we found that PARKIN localized to approximately 12% of wild-type M. tuberculosis phagosomes but not to ESX-1 mutants (Fig. 1a, Extended Data Fig. 1). Next, we infected BMDMs isolated from wild-type and Park2 mice and performed immunofluorescence co-localization experiments using antibodies that recognize polyubiquitin. As shown in Fig. 1b–c, Park2 BMDMs were severely defective for M. tuberculosis ubiquitin colocalization as compared to control macrophages, resulting in a significant reduction in ubiquitin-positive mycobacteria. Likewise, shRNA knock-down of PARKIN expression in human macrophage cell lines also resulted in a drastic reduction in ubiquitin localization with M. tuberculosis cells (Fig. 1d–f), indicating that PARKIN plays a conserved role in mycobacterium ubiquitination in mice and humans. Knock-down of LRSAM1, a ubiquitin ligase recently implicated in antibacterial defense and ubiquitination of Salmonella[1,3,4,13], had no effect on ubiquitin or GFP-LC3 colocalization with M. tuberculosis (Extended Data Fig. 1b, c). Expression of wild-type Park2 in Park2 cells restored ubiquitin localization around M. tuberculosis cells (Fig. 1g, h). In contrast, Park2 BMDMs expressing either of two pathogenic RING domain mutant alleles that inactivate PARKIN’s E3 ligase activity, T240R or P437L[3,4,14-16], failed to restore ubiquitin colocalization with M. tuberculosis (Fig. 1g, h). Taken together, these data demonstrate that Parkin and its E3 ligase activity are critical for the colocalization of ubiquitin with M. tuberculosis during infection.
Figure 1

PARKIN activity is required for M. tuberculosis-ubiquitin colocalization

a, Wild-type (WT) and Park2−/− BMDMs were infected with mCherry-expressing M. tuberculosis for 4 h and immunostained using anti-PARKIN antibodies. b, Wild-type BMDMs were infected with mCherry-M. tuberculosis for 4 h and immunostained for polyubiquitin. c, Quantification of ubiquitin-positive M. tuberculosis from (b). Results are means ± SEM of three independent experiments (**P<0.001, paired Student’s t-test). d, U937 human macrophages expressing a scrambled shRNA (Control) or one of two different shRNAs targeting Park2 (shRNA#1, shRNA#2) were infected with mCherry-M. tuberculosis for 12 h and immunostained for polyubiquitin. e, Quantification of ubiquitin positive M. tuberculosis from (d), results are means ± SEM of three independent experiments (**P<0.005, Student’s t-test). f, PARKIN and actin expression in cells from (e) was determined by western blotting. g, Park2−/− BMDMs were transduced with lentivirus expressing BFP (−), wild-type PARKIN, or two separate mutant PARKIN alleles (T240R, P437L). Cells were infected with M. tuberculosis for 4 h and ubiquitin-M. tuberculosis colocalization was quantified and expressed relative to control BMDMs. Results are means ± SEM of three independent experiments (**P<0.005, paired Student’s t-test). h, PARKIN and actin expression in cells from (g) was determined by western blotting.

PARKIN mediates K63-linked polyubiquitin

We showed previously that both K63- and K48-linked polyubiquitin chains accumulate around M. tuberculosis[3]. Because PARKIN is known to catalyze K63-linked ubiquitin chains[5,17], we sought to determine the nature of the residual ubiquitin surrounding M. tuberculosis in Park2 BMDMs. Using ubiquitin linkage-specific antibodies[5,18], we found that in wild-type BMDMs, approximately 26–29% of all intracellular bacteria (~90–95% of all ubiquitin-positive bacilli) co-localized with K63 ubiquitin, whereas only 5–7% bacilli stained for K48 (Fig. 2a–b). Additionally, expression of HA-epitope-tagged forms of K48 and K63 ubiquitin within BMDMs supported the notion that K63-linked polyubiquitin is more abundant surrounding M. tuberculosis than the K48-linked form (Extended Data Fig. 2). In Park2 BMDMs, however, there was a specific decrease in the number of K63-positive mycobacteria, while the K48-positive population remained unaffected (Fig. 2a–b, Extended Data Fig. 2). Previous electron microscopy studies indicated that though ubiquitin can localize directly with M. tuberculosis, the majority of ubiquitin is found on membranous structures surrounding M. tuberculosis-containing phagosomes[15,19-21]. To address whether bacterial or host proteins become ubiquitinated, we used a digitonin-based method that specifically permeabilizes the plasma membrane and leaves phagosomes intact with luminal contents inaccessible to antibodies[10,22] (Extended Data Fig. 3a). As shown in Extended Data Fig. 3b, antibodies against poly-ubiquitin and K63-ubiquitin stained digitonin-permeabilized cells and resulted in colocalization with mCherry-expressing M. tuberculosis. Importantly, anti- M. tuberculosis antibodies failed to stain M. tuberculosis within digitonin-permeabilized cells and only stained cells after addition of Triton-X100 detergent, demonstrating that digitonin permeabilized cells contained intact phagosomes (Extended Data Fig. 3b, c). Taken together, these data suggest that PARKIN facilitates the linkage of K63-linked ubiquitin chains surrounding M. tuberculosis containing phagosomes, although the exact protein target(s) remain to be explored. Furthermore, this data also suggests at least one other ubiquitin ligase works independently of PARKIN to catalyze the K48-linked ubiquitination that surrounds a minor population of M. tuberculosis cells.
Figure 2

PARKIN mediates K63-ubiquitin colocalization of M. tuberculosis and recruitment of ubiquitin-autophagy receptors

a, BMDMs were infected with mCherry-M. tuberculosis for 4 h and immunostained using linkage-specific ubiquitin antibodies. b, Quantification of K63 and K48 ubiquitin positive M. tuberculosis from (a). (**P<0.001, paired Student’s t-test). c, Same as (a) except immunostained for NDP52, p62, phospho-TBK1, or NBR1. d, Quantification of colocalization from (c), (N=3 per group, **P < 0.001).

PARKIN required for TB autophagy

Ubiquitination coincides with autophagic targeting of M. tuberculosis, but a causal relationship has not been demonstrated. To determine whether Parkin-mediated ubiquitination directs autophagic targeting of M. tuberculosis, we infected wild-type and Park2 macrophages with M. tuberculosis and measured colocalization of bacilli with multiple markers of autophagy. Microscopy analysis of proteins involved in ubiquitin recognition (NBR1, NDP52, p62, phospho-TBK1) revealed reduced colocalization with M. tuberculosis in Park2 macrophages (Fig. 2c–d), suggesting that PARKIN-mediated ubiquitination directly leads to the recruitment of the proximal ubiquitin-adaptors that facilitate autophagic targeting of mycobacteria. Likewise, mycobacterial cells within infected Park2 BMDMs had reduced colocalization with autophagic proteins LC3 and ATG12 relative to infection of wild-type BMDMs (Fig. 3a–b), suggesting that the K63-linked polyubiquitin catalyzed by PARKIN is required for delivery of M. tuberculosis to autophagosomes. Consistent with this notion, Park2 cells were defective in conversion of LC3 to its activated, lipidated form, LC3-II, during M. tuberculosis infection, further demonstrating that Parkin is required for autophagy of mycobacteria (Fig. 3c).
Figure 3

PARKIN mediates autophagic targeting of M. tuberculosis and limits replication

a, BMDMs were infected with mCherry-M. tuberculosis for 4 h and immunostained for LC3 or ATG12. b, Quantification of results from (a) (N=3 per group, **P < 0.001). c, Western blot analysis of LC3b from cell lysates from (a). d, BMDMs were infected with mCherry-M. tuberculosis for 6 h and immunostained for Lamp1. e, Quantification of results from (d) expressed relative to control BMDMs (N=3 per group, **P < 0.001). f, BMDMs were infected with M. tuberculosis and colony forming units (CFU) at t=0 and t=16 h were determined by plating. Results were normalized to t=0 (N=3 per group, *P < 0.02). g, 33 RAW264.7 macrophages transduced with lentivirus expressing GFP or PARKIN were infected with M. tuberculosis and CFU were determined after 16 h, results were normalized to GFP-expressing cells (N=3 per group, **P < 0.0076). h, U937 human macrophages expressing either scrambled or Park2 shRNAs were infected with M. tuberculosis for 36 h and CFU were determined. Results were normalized to t=0 (N=3 per group, *P < 0.02).

PARKIN limits TB replication

The autophagy pathway serves to limit M. tuberculosis replication in macrophages by delivering bacilli to the lysosome[3,11]. To determine if PARKIN mediated ubiquitination is required for autophagic targeting of M. tuberculosis to lysosomes, we infected BMDMs with M. tuberculosis and monitored co-localization with the lysosomal marker, LAMP1. During M. tuberculosis infection of wild-type BMDMs, approximately 30% of bacilli stained positive for LAMP1 at 6 hrs post-infection (Fig. 3d–e). In contrast, only 2–5% of bacilli colocalized with LAMP1 during M. tuberculosis infection of Park2 macrophages. This was similar to macrophages deficient for the essential autophagy protein, ATG5 (Fig. 3d–e)[3,5]. To test whether these differences led to changes in bacterial survival, we infected Park2−/− and Atg5−/− BMDMs with wild-type M. tuberculosis and determined bacterial viability by enumerating colony-forming units (CFUs). Infection of BMDMs deficient for either ATG5 or PARKIN resulted in a 2- and 2.5-fold increase in bacterial numbers, respectively, relative to control BMDMs by 12 hours post-infection (Fig. 3f). Conversely, overexpression of PARKIN in RAW 264.7 macrophages led to decreased bacterial replication (Fig. 3g). Importantly, knock-down of PARKIN expression in human U937 cells also led to an increase in bacterial replication during infection (Fig. 3h). Taken together, our data demonstrates that PARKIN-mediated ubiquitination leads to the autophagic targeting of M. tuberculosis and is essential for inhibition of mycobacterial replication in macrophages.

PARKIN mediates M. tuberculosis immunity

Polymorphisms within the regulatory region of Park2 in human populations have been identified as a common risk factor for increased susceptibility to Mycobacterium leprae and salmonella infection[6,7,10,11], suggesting that PARKIN plays an important role in vivo against a broad range of intracellular bacterial infections. We began to test this by first determining whether PARKIN was required in vivo during M. tuberculosis infection of mice. We performed a low-dose aerosol infection of wild-type and Park2−/− knockout mice and determined mouse survival and bacterial burden within infected tissues. In comparison to infected wild-type mice, Park2−/− knockout mice had a 10-fold increase in bacterial CFUs within infected lungs, spleens and liver by 21 days post-infection (Fig. 4a, b). Furthermore, survival studies revealed that Park2−/− mice were extremely susceptible to M. tuberculosis as all infected mice succumbed to overwhelming infection by 85 days post-infection, while all infected wild-type mice remained alive and displayed no-overt signs of weight-loss or stress (Fig. 4c). Immunohistochemistry staining of infected mouse lungs revealed robust PARKIN expression in mouse granulomas within the central macrophage containing zone (Fig. 4d). In agreement with our mouse experiments, we also observed high expression of PARKIN within human lung granuloma tissue samples from M. tuberculosis infected patients (Fig. 4e, Extended Data Fig. 4). Further analysis of human lung specimens via confocal microscopy revealed the presence of PARKIN puncta within M. tuberculosis infected cells as well as in vivo colocalization of PARKIN with M. tuberculosis (Fig. 4f). Lastly, Park2−/− mice were also highly susceptible to another intracellular pathogen, L. monocytogenes, resulting in 10–20 fold higher bacterial burdens relative to wild-type mice within infected spleens and liver (Fig. 4g). Taken together, this data demonstrates that PARKIN is essential in vivo for controlling intracellular bacterial pathogens within mice and suggests an in vivo role for Parkin in human tuberculosis disease.
Figure 4

PARKIN is required for control of bacterial infection in vivo

a, WT and Park2−/−mice were infected with wild-type M. tuberculosis via aerosol and lung bacterial burdens were determined by plating (means ± SD, N=5 per group, *P<0.02 by Student’s t-test). b, Enumeration of liver and spleen CFU from mice infected in (a) 21 days post-infection. (means ± SD, N=5 per group, *P<0.03 by Student’s t-test). c, Survival of M. tuberculosis-infected WT and Park2−/− mice (N=10, **P<0.001 by log-rank test). d, Immunohistochemistry staining of lung sections from infected mice 21 days post-infection, scale bar = 100μm. e, Immunohistochemistry staining of lung sections from a human patient with active tuberculosis. f, Confocal microscopy images of human lung sections from (e) immunostained for M. tuberculosis and PARKIN; DNA was visualized using DAPI. g, Mice were infected with WT L. monocytogenes via IP injection and bacterial burdens in livers and spleens were determined by plating (means ± SD, N=7 per group, *P<0.04 by Student’s t-test).

Conserved role of PARKIN in immunity

Park2 is present in all metazoans[8,23], including Drosophila melanogaster and Caenorhabditis elegans, with well-characterized functions in mitochondrial maintenance and in models of Parkinson’s disease. Because xenophagy of intracellular pathogens is a highly evolutionarily conserved innate immune defense mechanism[24], we sought to determine whether Parkin also plays an evolutionarily conserved role in immunity within non-mammalian organisms. We began by first analyzing PARKIN-deficient D. melanogaster strains using models of bacterial systemic infection. We obtained two mutant fly lines with independent disruptions of the Parkin gene (Park01950, Parkc00062) and infected them with L. monocytogenes, which has previously shown to induce autophagy within flies[25,26]. In contrast to wild-type infected flies, Parkin mutants were severely defective in ATG8/LC3 processing during infection (Fig. 5a), suggesting that Parkin plays a role in autophagic immunity within flies. Consistent with our results in mice, Parkin mutant flies were also highly susceptible to L. monocytogenes infection and led to 10–50 fold increases in bacterial burdens relative to wild-type infected flies (Fig. 5b). This was accompanied with decreased survival, with a median lifespan of two days following infection (Fig. 5c). In addition, Parkin mutant flies were also susceptible to other autophagy inducing intracellular pathogens such as S. Typhimurium and Mycobacterium marinum. By 9 hours post infection, Parkin deficient flies had a 10-fold increase in S. Typhimurium burden relative to wild-type flies (Fig. 5d). Moreover, PARKIN mutant flies had significantly decreased life spans upon infection with either S. Typhimurium (Fig. 5e) or M. marinum (Fig. 5f). Lastly, C. elegans strains deficient in the Parkin homolog (PDR-1) were also highly susceptible to S. Typhimurium infection (data not shown). All together, our data shows that Parkin homologs within lower metazoans are required for proper immune response to infection, suggesting an evolutionarily conserved role in innate immunity.
Figure 5

PARKIN is required for control of S. Typhimurium and M. marinum infection within flies

a, WT and two independent Parkin-deficient D. melanogaster lines (Parkc00062, Park01950) were infected with L. monocytogenes via anterior abdomen injection. ATG8 processing was monitored in whole-fly protein lysates by western blotting. b, L. monocytogenes CFU from (a) were determined by plating (means ± SD, N=3–5, **P<0.001 by Student’s t-test) and c, survival of D. melanogaster was determined (N=33, **P<0.001 by log-rank test). d, e, Flies were infected with S. Typhimurium and d, bacterial CFU (means ± SD, N=3–5 per group, **P<0.009 by Student’s t-test) and e, fly survival were determined (N=59, **P<0.001 by log-rank test). f, Survival of flies infected with M. marinum (N=37, **P<0.0045 by log-rank test).

Discussion

Our findings reveal that PARKIN regulates a common cellular program by which metazoans mediate quality control of endogenous mitochondria (self) and eradicate harmful bacterial pathogens (non-self). Although these two activities are seemingly disparate, the evolutionary origin of mitochondria from a bacterial endosymbiont suggests that perhaps mitochondrial dysfunction triggers the recognition of the organelle as non-self. For example, mitochondria (and bacterial endosymbionts[5,27]) may actively evade PARKIN surveillance, but these inhibitory processes are overridden upon organelle damage. Alternatively, several studies have shown that damaged mitochondria may serve as a “danger-associated molecular pattern”, resulting in the activation of several innate immune receptors such as toll-like receptors and the NLRP3-inflammasome complex[28,29]. In view of recent studies showing that intracellular infection with several pathogens such as L. monocytogenes result in altered host mitochondria dynamics[30], it is tempting to speculate that damaged mitochondria may serve as a signal for intracellular infection and activation of xenophagy. Our results also provide a molecular explanation for increased bacterial susceptibility of humans with polymorphisms in the Park2 regulatory region[3,10,11], broadening the role of PARKIN beyond mitochondrial homeostasis. Indeed, several recent studies have shown PARKIN to participate in a wide array of cellular processes such as apoptosis[31], regulation of lipid metabolism[32], and cytokine production upon infection[33], all of which may contribute to the in vivo importance of PARKIN in immunity. Lastly, this work highlights the unexpected connection between mitochondrial-based neuronal disorders and susceptibility to bacterial infection in humans. Recent genome wide association studies on inflammatory bowel disease, which is linked to altered host-gut microbe interactions, have identified susceptibility SNPs within LRRK2 and Park7, two genes canonically associated with Parkinson’s disease[34,35]. Thus, we surmise that genes typically associated with neuronal maintenance or mitophagy may play broad roles in cellular homeostasis within various cell types.

Full Methods

Mice and macrophages

Park2 mice on the C57L/B6 background were a gift from K. Nakamura (Gladstone Institute)[12,36]. GFP-LC3 transgenic mice on the C57L/B6 were a gift from N. Mizushima and used were as previously described[3]. Wild-type C57BL/6 mice were purchased from Jackson laboratories. BMDMs were obtained from mouse femurs as previously described[3] and cultured in DMEM H-21 supplemented with 20% FBS and 10% MCSF derived from 3T3-MCSF cells. U937 and Raw264.7 cells were obtained from ATCC and tested for mycoplasma prior to purchase. U937 monocytes were stimulated overnight with 20ng/ml of PMA (Sigma) prior to infections.

Antibodies

The following antibodies were used: LC3B (L10382 Invitrogen), NDP52 (Abnova D01), p62/SQSTM1 (Abnova 2C11), rabbit anti-drosophila ATG-8 (Gift from S. Cherry, U Penn), anti-Mtb (BEI Resources NR-13818), poly-ubiquitin (Enzo FK1), phospho-TBK1 (Cell Signaling #5483), Tubulin (Cell Signaling #2128), mouse-monoclonal Parkin (Cell Signaling #4211) and ATG12 (Cell Signaling #2011), rabbit polyclonal anti-Parkin (Abcam 15954), anti-NBR1 (Abcam 55474), humanized rabbit monoloncal antibodies specific for K63 or K48 (Gift from E. Brown lab at Genentech).

Bacterial strains

The following bacterial strains were used: M. tuberculosis (Erdman), L. monocytogenes (10403s), M. marinum (M), and S. Typhimurium (SL1344). Wild-type and ΔesxA mycobacteria expressing mCherry was previously described[3].

Macrophage infection

For infections with M. tuberculosis, macrophages were infected as previously described[3]. Briefly, M. tuberculosis cultures were washed twice with PBS, gently sonicated to disperse clumps, and resuspended in DMEM supplemented with 10% horse serum. Media was removed from cells, monolayers overlaid with the bacterial suspension, and centrifuged for 10 min at 1,000 RPM. Cells were washed twice in PBS and returned to macrophage media. For determination of bacterial viability following infection, cells were lysed in 1% Triton-X 100 and plated on 7H10 solid media.

Western blotting

Protein lysates from cells and flies were obtained by lysis in RIPA buffer (Sigma) at the indicated time points. Micro BCA protein kit (Pierce) was used to measure protein levels and equal amounts of protein were electrophoresed on 4–20% Tris-HCL Criterion gels (Biorad), and transferred onto nitrocellulose membranes. Western blots were analyzed using an Odyssey Imager (Licor) according to manufacturer’s instructions. Western blot figures are a representative of at least two independent experiments.

Immunofluorescence

Infected cells were immunostained and visualized as previously described[3]. Briefly, macrophages were seeded onto poly-lysine coated coverslips and infected with M. tuberculosis as described above. Cells were infected at an MOI of 1, and fixed in 4%PFA for 20 min at the indicated time points. Cells were incubated with indicated primary antibodies for 2 h at room temperature in 5% milk, 0.05% saponin and visualized using secondary Alexa-fluor488 antibodies. For Parkin immunofluorescence, cells were stained using rabbit polyclonal anti-Parkin (Abcam15954) and an HRP conjugated donkey anti-rabbit secondary (1:100, Jackson Immunochemicals) followed by amplification with alexafluor-488 tyramide (Invitrogen). Colocalization studies were performed as blinded experiments, with a minimum count of 200 cells per coverslip and performed in triplicate. Data shown is the mean ± SEM of at least 3 experiments.

Mouse infection

Non-randomized mice (female 5–8 weeks old) were infected with M. tuberculosis via low-dose aerosol infection (200 CFU) as previously described[37]. Sample size (N=5 per group) was based on empirical evidence from previously published reports[37] as the size necessary for adequate statistical analysis. Lungs, liver and spleens were harvested, homogenized, and plated on 7H10 agar plates. For survival experiments, infected mice were euthanized when they had lost 15% of their maximal body weight. For L. monocytogenes infections, mice were infected via intraperitoneal injection with 4 × 105 bacteria. 96 hours post infection, liver and spleen from infected mice were homogenized and serial dilutions were plated onto BHI agar plates. No blinding was done for these animal studies and all mice were housed and treated humanely using procedures described in an animal care protocol approved by University of California, San Francisco, Institutional Animal Care and Use Committee.

Fly strains and infections

The white1118 strain (Bloomington stock center, stock 6326) was used as the wild-type parental strain for all experiments. The Parkc00062 and Park01950 alleles are from the Exelexis piggyBac transposon collection[38]. Parkc00062 was obtained from Bloomington stock center and Park01950 was obtained from the Exelexis collection at Harvard. Infections were done as previously described[39]. Male 5 to 7 day-old files were anesthetized with CO2 and injected L. monocytogenes (1000 CFU), S. Typhimurium (2500 CFU), or M. marinum (1000 CFU) in 50 nl of culture into the anterior abdomen. Infected flies were homogenized in PBS supplemented with 1% Triton X-100 and serial dilutions were plated onto solid media. For survival analysis, the number of dead flies was counted daily and analyzed via log-rank test.

Lentiviral virus knockdown and complementation

Lentivirus expressing shRNAs targeting Park2 and LRSAM1 transcripts were generated using the Mission PLKO.1 lentivirus system from Sigma. A lentivirus expressing a non-targeting scrambled shRNA was used as a control. U937 cells were transduced with lentivirus per manufacturer’s instructions and stable cell lines were generated via selection with puromycin. For transgene expression of Park2 and Park2 mutants, full length Park2 was cloned into pBluescript vector and RING domain mutants were generated using Quick-Change site directed mutagenesis kit (Stratagene). HA-tagged ubiquitin constructs were obtained from Addgene[31]. Lentivirus expressing protein constructs were generated using the pLentiX system[3]. RAW264.7 cells were transduced and selected on puromycin for 1 week. BMDM cells expressing lentiviral constructs were generated by transducing marrow cells from knockout mice with lentivirus followed by differentiation into macrophages as described above. During day 3 of differentiation, cells were selected with 5ug/ml of puromycin.

Statistics

Statistical analysis of data was performed using GraphPad Prism software (Graphpad; San Diego, CA). Two-tailed unpaired Student’s t tests were used for analysis of microscopy images and mycobacterium CFU assays. The Kaplan-Meir method was used to analyze mouse survival.

RNA isolation and qPCR

RNA was isolated and purified from cells using the Trizol micro-midi RNA isolation kit (Invitrogen) per manufacturer’s instructions. For qPCR analysis 2μg of RNA was reverse transcribed using the VILO cDNA synthesis kit (Invitrogen) and qPCR analysis was performed in triplicate using a MJ Research Opticon 3200 machine. Data graphed in figures are representative of at least three independent experiments.

Digitonin permeabilization

Differential digitonin permeabilization of infected macrophages was performed as previously described.[30]

Immunohistochemistry of mouse specimens

Paraffin embedded specimens were deparaffinized in xylene, subjected to heat mediated antigen-retrieval in 10mM sodium citrate (pH 6.0), permeabilized in 0.2% Triton-100 (Sigma), treated with mouse on mouse blocking reagent (Vector Laboratories), and blocked in 5% donkey sera. Parkin was detected using a mouse monoclonal anti-Parkin antibody (Cell signal #4211) (1:50) and an HRP-conjugated donkey anti-rabbit secondary (1:250, Jackson immunochemicals), amplified with AB reagent (Vectastain) and detected using DAB reagent (Thermo Scientific). Images were acquired using a Zeiss Axioplan 2 microscope.

Immunohistochemistry and immunofluorescence of human specimens

Human lung biopsy specimens were obtained from patients with active tuberculosis. Paraffin embedded specimens were deparaffinized in xylene, subjected to heat mediated antigen-retrieval in 10mM sodium citrate (pH 6.0), permeabilized in 0.2% Triton-100 (Sigma) and blocked in 5% donkey sera. For immunohistochemistry, Parkin was detected using a rabbit polyclonal anti-Parkin antibody (abcam) (1:25) and an HRP-conjugated donkey anti-rabbit secondary (1:250, Jackson immunochemicals), amplified with AB reagent (Vectastain) and detected using DAB reagent (Thermo Scientific). Images were acquired using a Zeiss Axioplan 2 microscope. For immunofluorescence, Parkin was identified using rabbit polyclonal anti-Parkin (Abcam15954) at 1:25 and an HRP conjugated donkey anti-rabbit secondary (1:100, Jackson Immunochemicals) followed by amplification with tyramide (1:50, Perkin Elmer). TB was identified using guinea pig anti-TB (1:25,) and an Alexa 488 conjugated donkey anti-guinea pig secondary (1:100, Jackson Immunochemicals). Images were acquired using a Leica TCS SP5 confocal microscope. All human tissue specimens were obtained with consent. This study of human tissue specimens has been exempted under 45 CFR 46.101(b) and was approved by the Institutional Review Board at the University of Texas Southwestern Medical Center.

Extended Data Figure 1. Quantification of PARKIN colocalization and effect of LRSAM1 knockdown in BMDMs

a, Quantification of PARKIN-positive M. tuberculosis in BMDMs from wild-type and Park2 mice, from Figure 1a. b, BMDMs from LC3-GFP transgenic mice were transduced with lentivirus expressing either a scrambled shRNA control (Ctrl) or shRNAs targeting either LRSAM1 or PARKIN. Lentiviral transduced cells were than infected with mCherry-expressing M. tuberculosis and the colocalization of GFP-LC3 and ubiquitin was quantified via immunofluorescence. *P<0.014, **P<0.008 by Student’s t-test b, RT-qPCR expression of LRSAM1 and PARKIN transcripts in lentiviral transduced cells from (a). Data shown is expressed relative to actin expression. *P<0.033, **P<0.0035 by Student’s t-test.

Extended Data Figure 2. Colocalization of HA-ubiquitin species during M. tuberculosis infection

a, Wild-type BMDMs were transduced with lentivirus expressing HA-tagged constructs of wild-type ubiquitin (WT), ubiquitin with all lysine residues mutated to arginine except for lysine 63 (K63), or ubiquitin with all lysine residues mutated to arginine except for lysine 48 (K48). Transduced cells were then infected with mCherry-expressing M. tuberculosis and immunostained using anti-HA antibodies 4 hours post-infection. b, Quantification of HA-ubiquitin colocalization with M. tuberculosis from (a). **P<0.001 by Student’s t-test.

Extended Data Figure 3. Digitonin permeabilization of BMDMs

a, Cartoon model explaining digitonin differential permeabilization of macrophages and antibody accessibility to phagosomes. b, Microscopy images of Wild-type BMDMs were infected with mCherry expressing M. tuberculosis. Cells were immunostained via digitonin permeabilization alone or digitonin permeabilization with triton X-100 treatment. c, Quantification of ubiquitin colocalization with M. tuberculosis from (b). N.D., not determined.

Extended Data Figure 4. Immunohistochemistry analysis PARKIN within human patients with active tuberculosis

Lung biopsy samples were obtained from three different human patients with active tuberculosis. Immunohistochemistry was performed on specimens using either anti-PARKIN, anti-M. tuberculosis or an IgG control antibody. Positive cells were visualized via DAB staining. Scale bar = 1003m.
  39 in total

Review 1.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

2.  The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax.

Authors:  Bethann N Johnson; Alison K Berger; Giuseppe P Cortese; Matthew J Lavoie
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-29       Impact factor: 11.205

3.  Autophagy regulates Wolbachia populations across diverse symbiotic associations.

Authors:  Denis Voronin; Darren A N Cook; Andrew Steven; Mark J Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

4.  Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth.

Authors:  Philipp Wild; Hesso Farhan; David G McEwan; Sebastian Wagner; Vladimir V Rogov; Nathan R Brady; Benjamin Richter; Jelena Korac; Oliver Waidmann; Chunaram Choudhary; Volker Dötsch; Dirk Bumann; Ivan Dikic
Journal:  Science       Date:  2011-05-26       Impact factor: 47.728

5.  ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria.

Authors:  Diane Houben; Caroline Demangel; Jakko van Ingen; Jorge Perez; Lucy Baldeón; Abdallah M Abdallah; Laxmee Caleechurn; Daria Bottai; Maaike van Zon; Karin de Punder; Tridia van der Laan; Arie Kant; Ruth Bossers-de Vries; Peter Willemsen; Wilbert Bitter; Dick van Soolingen; Roland Brosch; Nicole van der Wel; Peter J Peters
Journal:  Cell Microbiol       Date:  2012-05-08       Impact factor: 3.715

6.  The LRR and RING domain protein LRSAM1 is an E3 ligase crucial for ubiquitin-dependent autophagy of intracellular Salmonella Typhimurium.

Authors:  Alan Huett; Robert J Heath; Jakob Begun; Slim O Sassi; Leigh A Baxt; Jatin M Vyas; Marcia B Goldberg; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2012-12-13       Impact factor: 21.023

7.  Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway.

Authors:  Robert O Watson; Paolo S Manzanillo; Jeffery S Cox
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

8.  ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells.

Authors:  Alessandra Romagnoli; Marilena P Etna; Elena Giacomini; Manuela Pardini; Maria Elena Remoli; Marco Corazzari; Laura Falasca; Delia Goletti; Valérie Gafa; Roxane Simeone; Giovanni Delogu; Mauro Piacentini; Roland Brosch; Gian Maria Fimia; Eliana M Coccia
Journal:  Autophagy       Date:  2012-08-13       Impact factor: 16.016

9.  Listeria monocytogenes transiently alters mitochondrial dynamics during infection.

Authors:  Fabrizia Stavru; Frédéric Bouillaud; Anna Sartori; Daniel Ricquier; Pascale Cossart
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-14       Impact factor: 11.205

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  260 in total

Review 1.  Autophagy and checkpoints for intracellular pathogen defense.

Authors:  Geraldine L C Paulus; Ramnik J Xavier
Journal:  Curr Opin Gastroenterol       Date:  2015-01       Impact factor: 3.287

2.  Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.

Authors:  Arun K Haldar; Clémence Foltz; Ryan Finethy; Anthony S Piro; Eric M Feeley; Danielle M Pilla-Moffett; Masaki Komatsu; Eva-Maria Frickel; Jörn Coers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

Review 3.  Autophagy and autophagy-related proteins in the immune system.

Authors:  Shusaku T Shibutani; Tatsuya Saitoh; Heike Nowag; Christian Münz; Tamotsu Yoshimori
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

4.  Structure of the Human Atg13-Atg101 HORMA Heterodimer: an Interaction Hub within the ULK1 Complex.

Authors:  Shiqian Qi; Do Jin Kim; Goran Stjepanovic; James H Hurley
Journal:  Structure       Date:  2015-08-20       Impact factor: 5.006

5.  Trends in Symbiont-Induced Host Cellular Differentiation.

Authors:  Shelbi L Russell; Jennie Ruelas Castillo
Journal:  Results Probl Cell Differ       Date:  2020

6.  Actin-based motility allows Listeria monocytogenes to avoid autophagy in the macrophage cytosol.

Authors:  Mandy I Cheng; Chen Chen; Patrik Engström; Daniel A Portnoy; Gabriel Mitchell
Journal:  Cell Microbiol       Date:  2018-05-30       Impact factor: 3.715

7.  A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis.

Authors:  Rui Kang; Ling Zeng; Yangchun Xie; Zhengwen Yan; Borong Zhou; Lizhi Cao; Daniel J Klionsky; Kevin J Tracey; Jianhua Li; Haichao Wang; Timothy R Billiar; Jianxin Jiang; Daolin Tang
Journal:  Autophagy       Date:  2016-10-18       Impact factor: 16.016

8.  Pioglitazone restores phagocyte mitochondrial oxidants and bactericidal capacity in chronic granulomatous disease.

Authors:  Ruby F Fernandez-Boyanapalli; S Courtney Frasch; Stacey M Thomas; Kenneth C Malcolm; Michael Nicks; Ronald J Harbeck; Claudia V Jakubzick; Raphael Nemenoff; Peter M Henson; Steven M Holland; Donna L Bratton
Journal:  J Allergy Clin Immunol       Date:  2014-12-10       Impact factor: 10.793

9.  TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage Homeostasis.

Authors:  Santosh Chauhan; Suresh Kumar; Ashish Jain; Marisa Ponpuak; Michal H Mudd; Tomonori Kimura; Seong Won Choi; Ryan Peters; Michael Mandell; Jack-Ansgar Bruun; Terje Johansen; Vojo Deretic
Journal:  Dev Cell       Date:  2016-09-29       Impact factor: 12.270

10.  E3 ubiquitin ligase NKLAM ubiquitinates STAT1 and positively regulates STAT1-mediated transcriptional activity.

Authors:  Donald W Lawrence; Jacki Kornbluth
Journal:  Cell Signal       Date:  2016-08-26       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.